Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) announced its quarterly earnings data on Monday. The specialty pharmaceutical company reported ($0.18) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by $0.07, Bloomberg Earnings reports. Acura Pharmaceuticals had a net margin of 14.91% and a return on equity of 112.19%. The business had revenue of $0.09 million during the quarter.

Acura Pharmaceuticals (ACUR) opened at 0.4695 on Tuesday. The firm’s market capitalization is $5.58 million. Acura Pharmaceuticals has a one year low of $0.40 and a one year high of $1.87. The company has a 50-day moving average of $0.51 and a 200 day moving average of $0.57.

TRADEMARK VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.watchlistnews.com/acura-pharmaceuticals-inc-acur-announces-quarterly-earnings-results-misses-estimates-by-0-07-eps/1490125.html.

Acura Pharmaceuticals Company Profile

Acura Pharmaceuticals, Inc is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products.

Earnings History for Acura Pharmaceuticals (NASDAQ:ACUR)

Receive News & Ratings for Acura Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.